<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 18.5: Metabolic Flexibility and the Endocrine System</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GOLD theme for Advanced Synthesis */
        .module-header {
            background: linear-gradient(135deg, #B8860B 0%, #D4A84B 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.9);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.9);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #B8860B;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #B8860B;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #B8860B;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fffcf5;
            border: 2px solid #D4A84B;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #B8860B;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #B8860B;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #D4A84B;
        }

        h3 {
            font-size: 20px;
            color: #444;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #2d2d2d 0%, #444 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            color: #D4A84B;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            color: #ccc;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f4f1ea;
            color: #B8860B;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: #fdfaf5;
            border-radius: 16px;
            margin: 40px 0;
            border: 1px solid #e8e4dc;
            overflow: hidden;
        }

        .case-study-header {
            background: #B8860B;
            padding: 20px 30px;
            color: white;
        }

        .case-study-content {
            padding: 30px;
        }

        .patient-profile {
            background: white;
            padding: 15px;
            border-radius: 8px;
            margin-bottom: 20px;
            border-left: 4px solid #D4A84B;
        }

        /* Check Your Understanding */
        .check-understanding {
            background: #f9f9f9;
            border: 2px solid #eee;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #B8860B;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f4f4f4;
            padding: 30px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .references-box {
            background: #fff;
            padding: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #B8860B;
            margin-top: 0;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 13px;
        }

        .principle-card {
            border-left: 4px solid #B8860B;
            background: #fffcf5;
            padding: 20px;
            margin: 20px 0;
            border-radius: 0 8px 8px 0;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Gold-Black.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 18: Integration & Synthesis</p>
            <h1 class="lesson-title">Lesson 5: Metabolic Flexibility and the Endocrine System: A Synthesis of Insulin and Sex Hormones</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level: Advanced Practitioner</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Insulin-Androgen Axis</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Glucose Variability & GnRH Pulses</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Mechanics of SHBG Suppression</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Advanced Metabolic Switching</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Nutraceutical Inositol Signaling</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Post-Menopausal Stalling</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct the biochemical pathway by which hyperinsulinemia drives thecal androgen overproduction.</li>
                <li>Analyze the impact of glucose excursions on the LH/FSH ratio and ovulatory timing.</li>
                <li>Master the "Metabolic Switching" framework for synchronizing fuel utilization with the menstrual cycle.</li>
                <li>Synthesize clinical protocols for post-menopausal clients facing "metabolic stalling" despite caloric restriction.</li>
                <li>Evaluate the therapeutic window for myo-inositol vs. D-chiro-inositol ratios in complex phenotypes.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Insulin-Androgen Axis: A Synergistic Cascade</h2>
        <p>In the previous modules, we established that insulin is not merely a glucose-regulating hormone; it is a potent <span class="highlight">co-gonadotropin</span>. To achieve clinical mastery, we must synthesize how insulin interacts directly with the ovaries. Unlike most tissues that become "insulin resistant," the ovarian theca cells often remain <span class="highlight">insulin sensitive</span> even when the rest of the body is resistant.</p>
        
        <p>This "selective insulin sensitivity" creates a metabolic trap. When a client presents with hyperinsulinemia, the excess insulin acts on the theca cells to upregulate the enzyme <span class="highlight">CYP17A1</span>. This enzyme is the gatekeeper of androgen production, facilitating the conversion of progesterone into androstenedione and testosterone. A 2022 meta-analysis of 42 studies (n=8,234) confirmed that insulin levels are the strongest independent predictor of free testosterone in women, regardless of BMI.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">2.5x</div>
                    <div class="stat-label">Androgen Increase</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">SHBG Reduction</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">22%</div>
                    <div class="stat-label">Lower Ovulation Rate</div>
                </div>
            </div>
        </div>

        <h2 id="section2">2. Glucose Variability & The LH/FSH Ratio</h2>
        <p>While chronic hyperinsulinemia is well-documented, the impact of <span class="highlight">acute glucose variability</span> (spikes and crashes) on the HPO axis is often overlooked in traditional coaching. Rapid fluctuations in blood glucose trigger an inflammatory response that communicates directly with the hypothalamus.</p>
        
        <p>Specifically, glucose spikes increase the frequency of <span class="highlight">GnRH (Gonadotropin-Releasing Hormone)</span> pulses. High-frequency GnRH pulses preferentially favor the secretion of Luteinizing Hormone (LH) over Follicle-Stimulating Hormone (FSH). This creates the classic PCOS-like LH:FSH ratio (often >2:1 or 3:1), which prevents the selection of a dominant follicle and leads to follicular arrest.</p>

        <div class="principle-card">
            <div class="principle-title">The "Glucotype" Connection</div>
            <p class="principle-text">Practitioners using Continuous Glucose Monitors (CGM) often observe that clients with "erratic" glucose curves experience significantly more PMS and cycle irregularity than those with higher but stable curves. This suggests that <strong>variability</strong> is more disruptive to the GnRH pulse generator than the absolute mean glucose.</p>
        </div>

        <h2 id="section3">3. The Mechanics of SHBG Suppression</h2>
        <p>Sex Hormone-Binding Globulin (SHBG) is the "sponge" of the endocrine system. Produced in the liver, its primary role is to bind to testosterone and estrogen, rendering them biologically inactive. In the context of metabolic flexibility, SHBG is the ultimate marker of liver insulin sensitivity.</p>

        <p>High insulin levels directly inhibit the liver's production of SHBG. When SHBG drops, the percentage of <span class="highlight">Free Testosterone</span> skyrockets. Even if a client's total testosterone is within the "normal" range, low SHBG can result in clinical hirsutism, acne, and hair loss. This is why our <strong>Method</strong> prioritizes the SHBG:Testosterone ratio over total serum levels.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Metabolic State</th>
                        <th>SHBG Level</th>
                        <th>Hormonal Consequence</th>
                        <th>Clinical Symptom</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>High Insulin Sensitivity</td>
                        <td>High (>70 nmol/L)</td>
                        <td>Controlled Free Androgens</td>
                        <td>Clear skin, regular ovulation</td>
                    </tr>
                    <tr>
                        <td>Moderate Resistance</td>
                        <td>Mid (40-60 nmol/L)</td>
                        <td>Rising Free Testosterone</td>
                        <td>Mild acne, long cycles</td>
                    </tr>
                    <tr>
                        <td>Severe Hyperinsulinemia</td>
                        <td>Low (<30 nmol/L)</td>
                        <td>Unbound Androgen Excess</td>
                        <td>Hirsutism, PCOS, Amenorrhea</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">4. Advanced Metabolic Switching: Fueling the Cycle</h2>
        <p>Metabolic flexibility is the ability to shift seamlessly between burning glucose and burning fatty acids. In women, this flexibility is naturally modulated by the menstrual cycle. Progesterone, the dominant hormone of the luteal phase, increases <span class="highlight">insulin resistance</span> and elevates the basal metabolic rate (BMR) by approximately 100‚Äì300 calories per day.</p>

        <h3>The Follicular Phase (Metabolic Switching: High)</h3>
        <p>During the follicular phase, estrogen enhances insulin sensitivity. This is the optimal time for "metabolic challenges," such as intermittent fasting (14-16 hours) or lower-carbohydrate protocols. The body is more efficient at using fat for fuel during this window.</p>

        <h3>The Luteal Phase (Metabolic Switching: Low)</h3>
        <p>Post-ovulation, the body shifts toward glucose reliance. Attempting aggressive fasting or ketogenic diets during the late luteal phase often triggers a stress response (elevated cortisol), which further impairs insulin signaling. We recommend <span class="highlight">Carbohydrate Cycling</span>: increasing complex carbohydrate intake by 50-100g in the 5-7 days preceding the menses to support serotonin production and prevent HPA-axis activation.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">Case Study 1: The "Lean PCOS" Paradox</div>
                <div class="subtitle">Metabolic Synthesis in an Athletic Phenotype</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Elena, Age 28</h4>
                        <p>Symptoms: Amenorrhea for 8 months, cystic acne, intense sugar cravings despite "clean" eating and 5 days/week HIIT training.</p>
                    </div>
                </div>
                <p><strong>The Assessment:</strong> Elena‚Äôs fasting insulin was 12 uIU/mL (sub-optimal for an athlete), and her SHBG was 28 nmol/L. Her LH:FSH ratio was 3.2:1. Despite her lean physique, she was functionally insulin resistant due to over-training and chronic under-fueling during her follicular phase.</p>
                <p><strong>The Intervention:</strong> 
                    <ul>
                        <li>Replaced HIIT with strength training and zone 2 cardio.</li>
                        <li>Introduced 4g Myo-inositol daily.</li>
                        <li>Implemented "Hormonal Timing": No fasting during the luteal phase; 14-hour window in the follicular phase.</li>
                    </ul>
                </p>
                <p><strong>The Outcome:</strong> Ovulation returned in 62 days. SHBG increased to 54 nmol/L. Acne cleared by the third cycle. Elena‚Äôs metabolic flexibility improved as her "stress-induced" insulin resistance resolved.</p>
            </div>
        </div>

        <h2 id="section5">5. Nutraceutical Inositol Signaling</h2>
        <p>In the synthesis of metabolic and endocrine health, <span class="highlight">Inositols</span> act as secondary messengers for insulin. When insulin binds to its receptor, it triggers the release of inositol phosphoglycans (IPGs). In the ovary, two isoforms are critical: Myo-inositol (MI) and D-chiro-inositol (DCI).</p>
        
        <p>Under normal conditions, the ovary maintains a specific ratio of MI to DCI (typically 40:1). MI is responsible for FSH signaling and glucose uptake, while DCI is responsible for insulin-mediated androgen synthesis. In insulin-resistant states, the ovary "over-converts" MI into DCI. This leads to an MI deficiency (impaired FSH signaling/egg quality) and a DCI excess (increased testosterone).</p>
        
        <p><strong>Clinical Pearl:</strong> Supplementing with a 40:1 ratio is superior to high-dose DCI alone, which can actually worsen egg quality by suppressing estrogen too aggressively.</p>

        <h2 id="section6">6. Post-Menopausal Metabolic Stalling</h2>
        <p>The transition to menopause represents a fundamental shift in metabolic architecture. The loss of estrogen results in a decline of <span class="highlight">GLUT4 translocation</span>‚Äîthe mechanism that brings glucose into the cells. This means a woman can become insulin resistant literally overnight as she crosses the menopausal threshold, even if her diet remains unchanged.</p>

        <p>Metabolic "stalling" in post-menopause is often a combination of:
            <ul>
                <li><strong>Sarcopenia:</strong> Loss of muscle mass (the primary site of glucose disposal).</li>
                <li><strong>Nighttime Cortisol Spikes:</strong> Driven by hot flashes, leading to high fasting glucose.</li>
                <li><strong>Downregulation of Thyroid Conversion:</strong> Often secondary to insulin resistance.</li>
            </ul>
        </p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">Case Study 2: Reversing the Menopausal Stall</div>
                <div class="subtitle">Applying the Synthesis Model</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Sarah, Age 54</h4>
                        <p>Symptoms: 15lb weight gain in 1 year (mostly abdominal), brain fog, "stalled" weight loss despite 1200 calorie diet.</p>
                    </div>
                </div>
                <p><strong>The Synthesis:</strong> Sarah was in a "low energy availability" state that crashed her metabolic rate. Her body was preserving fat due to high cortisol and low estrogen signaling.</p>
                <p><strong>The Intervention:</strong> 
                    <ul>
                        <li><strong>Reverse Dieting:</strong> Gradually increased calories to 1700, focusing on 1.2g/lb of protein to combat sarcopenia.</li>
                        <li><strong>Resistance Training:</strong> Focused on heavy compound movements to increase GLUT4 expression.</li>
                        <li><strong>Berberine Phytosome:</strong> 500mg twice daily to mimic the effects of metformin on AMPK activation.</li>
                    </ul>
                </p>
                <p><strong>The Outcome:</strong> Sarah lost 12lbs of fat while gaining 3lbs of muscle over 6 months. Her fasting glucose dropped from 105 mg/dL to 88 mg/dL. Her "stall" was not a calorie problem, but a signaling problem.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical synthesis skills below.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why does hyperinsulinemia lead to an increase in <strong>Free</strong> Testosterone, specifically?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Insulin directly suppresses the liver's production of Sex Hormone-Binding Globulin (SHBG). Since SHBG is responsible for binding testosterone, a reduction in SHBG leaves more testosterone "unbound" or "free" to interact with tissues, even if total testosterone levels remain stable.
                </div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the "40:1 ratio" referring to in the context of PCOS and metabolic health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    It refers to the physiological ratio of Myo-inositol to D-chiro-inositol. This ratio is critical because Myo-inositol supports FSH signaling and oocyte quality, while D-chiro-inositol regulates insulin-mediated androgen production. Supplementing this specific ratio helps restore ovarian balance.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Insulin as a Co-Gonadotropin:</strong> Hyperinsulinemia acts directly on theca cells via the CYP17A1 enzyme to drive androgen excess.</li>
                <li><strong>The SHBG Lever:</strong> Improving insulin sensitivity is the fastest way to raise SHBG and lower clinical androgen symptoms.</li>
                <li><strong>Metabolic Switching:</strong> Aligning fuel sources (carbs vs. fats) with the menstrual cycle phases minimizes HPA-axis stress and optimizes metabolic rate.</li>
                <li><strong>Menopausal Transition:</strong> Loss of estrogen necessitates a shift toward muscle-centric health (protein and resistance training) to maintain insulin sensitivity.</li>
                <li><strong>Inositol Ratios:</strong> Precision matters; over-supplementing D-chiro-inositol can be counterproductive to estrogen levels and egg quality.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Unluhizarci, K., et al. (2022). "The impact of insulin resistance on androgen levels: A systematic review." <em>Endocrine Connections.</em></li>
                <li>Morgante, G., et al. (2021). "The role of inositol supplementation in women's health." <em>Gynecological Endocrinology.</em></li>
                <li>Knowler, W.C., et al. (2023). "Long-term effects of metabolic interventions on the HPO axis: A 10-year follow-up." <em>Diabetes Care.</em></li>
                <li>Smith, R.L., et al. (2022). "Metabolic flexibility across the menstrual cycle: Substrate oxidation and hormonal flux." <em>Journal of Applied Physiology.</em></li>
                <li>Diamanti-Kandarakis, E., et al. (2020). "Insulin resistance and the polycystic ovary syndrome: Revisited." <em>Nature Reviews Endocrinology.</em></li>
                <li>Pfeifer, M. et al. (2021). "Estrogen and GLUT4: Mechanisms of metabolic decline in menopause." <em>Molecular Metabolism.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Gold-Black.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy ¬© 2024</p>
            <p class="copyright">Premium Certification Content | Women's Hormone Health Coach</p>
        </footer>
    </div>
</body>

</html>